-
公开(公告)号:US20240247013A1
公开(公告)日:2024-07-25
申请号:US18628116
申请日:2024-04-05
申请人: BASF SE
发明人: Stephen Craig Fields , Matthew Richard Oberholzer , Brian Michael Green , Samir Kulkarni , Jennifer Nelson , Patricia Andres
摘要: Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate. In some embodiments, a portion of the glutamate in the starting composition may be separated from the L-glufosinate using a crystallization step. Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium, are also described.
-
公开(公告)号:US11976089B2
公开(公告)日:2024-05-07
申请号:US18180701
申请日:2023-03-08
申请人: BASF SE
发明人: Stephen Craig Fields , Matthew Richard Oberholzer , Brian Michael Green , Samir Kulkarni , Jennifer Nelson , Patricia Andres
摘要: Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium, are described.
-
公开(公告)号:US20240108686A1
公开(公告)日:2024-04-04
申请号:US18329345
申请日:2023-06-05
发明人: Stephen Mark Robbins , Donna Lorraine Senger , Jennifer Joy Rahn , Arthur Wing SZE Lau , Daniel Abraham Muruve , Saurav Roy Choudhury , Liane Babes , Paul Kubes
IPC分类号: A61K38/17 , A61K9/00 , A61K31/662 , A61K31/664 , A61K38/08 , A61K38/10 , A61K38/55 , A61P13/12 , A61P29/00 , A61P35/04 , A61P37/06 , A61P43/00 , C07C323/58 , C07F9/30 , C07K16/40 , C12N9/48
CPC分类号: A61K38/1709 , A61K9/0019 , A61K31/662 , A61K31/664 , A61K38/08 , A61K38/10 , A61K38/55 , A61P13/12 , A61P29/00 , A61P35/04 , A61P37/06 , A61P43/00 , C07C323/58 , C07F9/302 , C07K16/40 , C12N9/485 , C12Y304/13019 , C07K2317/76
摘要: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
-
公开(公告)号:US20230399348A1
公开(公告)日:2023-12-14
申请号:US18299605
申请日:2023-04-12
发明人: Yongjiang Liu , Jie Cai , Min Xu , Tingying Liu , Lei Zhou , Wei Zeng , Ke Cheng , Yingsui Yin
IPC分类号: C07F9/30 , C07F9/48 , C07F9/50 , C07F9/535 , C07F9/6584
CPC分类号: C07F9/301 , C07F9/4883 , C07F9/5004 , C07F9/535 , C07F9/65844
摘要: Provided are a method for preparing L-glufosinate and the intermediate compounds of formula (V) and formula (III).
-
公开(公告)号:US20230330258A1
公开(公告)日:2023-10-19
申请号:US18054018
申请日:2022-11-09
发明人: Christian HACKENBERGER , Marc-André KASPER , Philipp OCHTROP , Jahaziel JAHZERAH , Paul MACHUI , Dominik SCHUMACHER , Jonas HELMA-SMETS , Isabelle MAI
CPC分类号: A61K47/6889 , C07F9/30
摘要: The present invention relates to a conjugate having the formula (I):
wherein a receptor binding molecule (RBM) is connected with a drug moiety (D). The present invention also relates to intermediates for producing the same, methods of preparing the same, pharmaceutical compositions comprising the same, as well as uses thereof.-
公开(公告)号:US20230227420A1
公开(公告)日:2023-07-20
申请号:US17959256
申请日:2022-10-03
发明人: Srinivas RAO , Glenn SHORT , Robert B. PERNI , Tanweer A. KHAN , Alan C. GIBBS
IPC分类号: C07D317/58 , C07D411/12 , C07F9/30
CPC分类号: C07D317/58 , C07D411/12 , C07F9/30
摘要: The present disclosure provides prodrug compounds of MDMA, MDA, and derivatives thereof having an improved pharmacokinetic profile suitable for the treatment of various neurological diseases.
-
公开(公告)号:US20230219984A1
公开(公告)日:2023-07-13
申请号:US18180681
申请日:2023-03-08
申请人: BASF SE
发明人: Stephen Craig Fields , Matthew Richard Oberholzer , Brian Michael Green , Samir Kulkarni , Jennifer Nelson , Patricia Andres
摘要: Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate. In some embodiments, a portion of the glutamate in the starting composition may be separated from the L-glufosinate using a crystallization step. Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium, are also described.
-
公开(公告)号:US11655265B2
公开(公告)日:2023-05-23
申请号:US17841410
申请日:2022-06-15
发明人: Yongjiang Liu , Jie Cai , Min Xu , Tingying Liu , Lei Zhou , Wei Zeng , Ke Cheng , Yingsui Yin
IPC分类号: C07F9/30 , C07F9/48 , C07F9/50 , C07F9/535 , C07F9/6584
CPC分类号: C07F9/301 , C07F9/4883 , C07F9/5004 , C07F9/535 , C07F9/65844
摘要: Provided are a method for preparing L-glufosinate and the intermediate compounds of formula (V) and formula (III).
-
公开(公告)号:US20230041504A1
公开(公告)日:2023-02-09
申请号:US17784533
申请日:2020-12-11
申请人: PHARMALEADS
发明人: Hervé Poras , Alain Priour , Guillaume Grach , Roberto Fanelli , Xinjun Zhao
IPC分类号: C07F9/30
摘要: The present invention relates to a method for the industrial preparation of ((2S)-3-([1,1′-biphenyl]-4-yl)-2-((((R)-1-aminoethyl)(hydroxy)phosphoryl)methyl)propanoyl)-L-alanine acid of following formula (E): from (S)-1-phenylethylamine via a multi-step synthesis.
The present invention pertains to a method for the industrial preparation of the disodium salt of ((2S)-3-([1,1′-biphenyl]-4-yl)-2-((hydroxy((1R)-1-(((1-(isobutyryloxy)ethoxy)carbonyl)amino)ethyl)phosphoryl)methyl)propanoyl)-L-alanine of following formula (I): in two additional steps from the compound (E) such as defined above.
The present invention also pertains to a method for diastereoisomeric enrichment of the intermediates of the method for the industrial preparation of the compound of formula (E) of the present invention.-
公开(公告)号:US20220389036A1
公开(公告)日:2022-12-08
申请号:US17876243
申请日:2022-07-28
发明人: Adam Duerfeldt , Jian-xing Ma , Xiaozheng Dou , Dinesh Nath , Young-Hwa Shin
摘要: Benzyl derivative compounds having peroxisome proliferator-activated receptor α (PPARα) agonistic activity, kits and compositions containing such compounds, and methods of their use in enhancing PPARα activity for treating diseases and/or conditions involving inflammation and/or angiogenesis, particularly ocular diseases and/or conditions such as but not limited to retinal inflammation, retinal neovascularization, retinal vascular leakage, retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, and diabetic macular edema.
-
-
-
-
-
-
-
-
-